The Effect of Antipsychotics on the High-Affinity State of D2 and D3 Receptors A Positron Emission Tomography Study With [11C]-(+)-PHNO

被引:82
|
作者
Graff-Guerrero, Ariel [2 ,3 ,4 ]
Mamo, David [2 ,3 ]
Shammi, C. M. [2 ,3 ]
Mizrahi, Romina [2 ,3 ]
Marcon, Heidi [3 ]
Barsoum, Penny [3 ]
Rusjan, Pablo [3 ]
Houle, Sylvain [2 ,3 ]
Wilson, Alan A. [2 ,3 ]
Kapur, Shitij [1 ,2 ,3 ]
机构
[1] Kings Coll London, Inst Psychiat, Div Psychol Med & Psychiat, London SE5 8AF, England
[2] Univ Toronto, Dept Psychiat, Toronto, ON M5S 1A1, Canada
[3] Ctr Addict & Mental Hlth, Positron Emission Tomog Ctr, Toronto, ON, Canada
[4] Univ Nacl Autonoma Mexico, Inst Neurobiol, Mexico City 04510, DF, Mexico
关键词
STRIATAL DOPAMINE RELEASE; RAT-BRAIN; CLINICAL-RESPONSE; BINDING; AGONIST; PET; SCHIZOPHRENIA; OCCUPANCY; RADIOTRACER; PRAMIPEXOLE;
D O I
10.1001/archgenpsychiatry.2009.43
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Context: Most antipsychotics are thought to have an effect on D-2 and D-3 receptors. The development of carbon 11-labeled (+)-4-propyl-9-hydroxynaphthoxazine ([C-11]-(+)-PHNO), the first agonist radioligand with higher affinity for D-3 than D-2 receptors, allows one to differentiate the effects of antipsychotics on high-affinity vs low-affinity sites of the D-2 receptor and on D-3 vs D-2 receptor subtypes. Objectives: To examine the effects of antipsychotics (clozapine, risperidone, or olanzapine) on the high-vs high-+low-affinity sites of the D-2 and D-3 receptors by comparing the [C-11]-(+)-PHNO and [C-11]raclopride binding in the D-3 receptor-rich (globus pallidus and ventral striatum) and D-2 receptor-rich (caudate and putamen) regions. Design: Two sequential studies with different participants and appropriate controls were performed. The first compared the occupancy produced by 3 antipsychotics as measured with [C-11]-(+)-PHNO and [C-11]raclopride. The second was a double-blind, placebo-controlled experiment to compare the effect of pramipexole (a D-3 receptor-preferring agonist) vs placebo on the increased [C-11]-(+)-PHNO signal observed in the globus pallidus of patients. Setting: Positron Emission Tomography Centre, Centre for Addiction and Mental Health, Toronto, Ontario, Canada. Participants: Twenty-three patients with schizophrenia and 23 healthy controls. Main Outcome Measures: Antipsychotic occupancies as measured with [C-11]-(+)-PHNO and [C-11]raclopride. Results: The antipsychotic-treated patients showed high occupancies with both [C-11]-(+)-PHNO and [C-11]raclopride in the dorsal striatum, with [C-11]raclopride occupancies about 20% higher. Most strikingly, patients did not show any occupancy with [C-11]-(+)-PHNO in the globus pallidus as compared with normal controls or with their own scans using [C-11]raclopride. This unblocked [C-11]-(+)-PHNO signal was displaced by a single dose of pramipexole. Conclusions: Antipsychotics block both the high-and low-affinity states of the D-2 receptors across the brain, but antipsychotic treatment does not block the [C-11](+)-PHNO signal in the D-3 receptor-rich regions, despite the ongoing D-2 receptor blockade. This [C-11]-(+)PHNO signal in regions such as the globus pallidus seems increased despite antipsychotic treatment and is displaceable by a D-3 receptor-preferring agonist. The radiotracer [C-11]-(+)-PHNO and the data open up new avenues for exploring the potential therapeutic significance of the D-3 receptor in schizophrenia.
引用
收藏
页码:606 / +
页数:12
相关论文
共 50 条
  • [11] Dopamine (D2/3) receptor agonist positron emission tomography radiotracer [11C)-(+)-PHNO is a D3 receptor preferring agonist in vivo
    Narendran, Rajesh
    Slifstein, Mark
    Guillin, Olivier
    Hwang, Yuying
    Hwang, Dah-Ren
    Scher, Erica
    Reeder, Stephanie
    Rabiner, Eugenii
    Laruelle, Marc
    SYNAPSE, 2006, 60 (07) : 485 - 495
  • [12] Similar striatal D2/D3 dopamine receptor availability in adults with Tourette syndrome compared with healthy controls: A [11C]-(+)-PHNO and [11C]raclopride positron emission tomography imaging study
    Abi-Jaoude, Elia
    Segura, Barbara
    Obeso, Ignacio
    Cho, Sang Soo
    Houle, Sylvain
    Lang, Anthony E.
    Rusjan, Pablo
    Sandor, Paul
    Strafella, Antonio P.
    HUMAN BRAIN MAPPING, 2015, 36 (07) : 2592 - 2601
  • [13] Occupancy of Dopamine D3 and D2 Receptors by Buspirone: A [11C]-(+)-PHNO PET Study in Humans
    Le Foll, Bernard
    Payer, Doris
    Di Ciano, Patricia
    Guranda, Mihail
    Nakajima, Shinichiro
    Tong, Junchao
    Mansouri, Esmaeil
    Wilson, Alan A.
    Houle, Sylvain
    Meyer, Jeff H.
    Graff-Guerrero, Ariel
    Boileau, Isabelle
    NEUROPSYCHOPHARMACOLOGY, 2016, 41 (02) : 529 - 537
  • [14] Comparison of Dopamine D3 and D2 Receptor Occupancies by a Single Dose of Blonanserin in Healthy Subjects: A Positron Emission Tomography Study With [11C]-(+)-PHNO
    Tateno, Amane
    Sakayori, Takeshi
    Kim, Woo-chan
    Honjo, Kazuyoshi
    Nakayama, Haruo
    Arakawa, Ryosuke
    Okubo, Yoshiro
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2018, 21 (06) : 522 - 527
  • [15] Preferential binding to dopamine D3 over D2 receptors by cariprazine in patients with schizophrenia using PET with the D3/D2 receptor ligand [11C]-(+)-PHNO
    Girgis, Ragy R.
    Slifstein, Mark
    D'Souza, Deepak
    Lee, Yih
    Periclou, Antonia
    Ghahramani, Parviz
    Laszlovszky, Istvan
    Durgam, Suresh
    Adham, Nika
    Nabulsi, Nabeel
    Huang, Yiyun
    Carson, Richard E.
    Kiss, Bela
    Kapas, Margit
    Abi-Dargham, Anissa
    Rakhit, Ashok
    PSYCHOPHARMACOLOGY, 2016, 233 (19-20) : 3503 - 3512
  • [16] Preferential binding to dopamine D3 over D2 receptors by cariprazine in patients with schizophrenia using PET with the D3/D2 receptor ligand [11C]-(+)-PHNO
    Ragy R. Girgis
    Mark Slifstein
    Deepak D’Souza
    Yih Lee
    Antonia Periclou
    Parviz Ghahramani
    István Laszlovszky
    Suresh Durgam
    Nika Adham
    Nabeel Nabulsi
    Yiyun Huang
    Richard E. Carson
    Béla Kiss
    Margit Kapás
    Anissa Abi-Dargham
    Ashok Rakhit
    Psychopharmacology, 2016, 233 : 3503 - 3512
  • [17] Estimating Endogenous Dopamine Levels at D2 and D3 Receptors in Humans using the Agonist Radiotracer [11C]-(+)-PHNO
    Caravaggio, Fernando
    Nakajima, Shinichiro
    Borlido, Carol
    Remington, Gary
    Gerretsen, Philip
    Wilson, Alan
    Houle, Sylvain
    Menon, Mahesh
    Mamo, David
    Graff-Guerrero, Ariel
    NEUROPSYCHOPHARMACOLOGY, 2014, 39 (12) : 2769 - 2776
  • [18] First Human Evidence of d-Amphetamine Induced Displacement of a D2/3 Agonist Radioligand: A [11C]-(+)-PHNO Positron Emission Tomography Study
    Matthäus Willeit
    Nathalie Ginovart
    Ariel Graff
    Pablo Rusjan
    Irina Vitcu
    Sylvain Houle
    Philip Seeman
    Alan A Wilson
    Shitij Kapur
    Neuropsychopharmacology, 2008, 33 : 279 - 289
  • [19] First human evidence of d-amphetamine induced displacement of a D2/3 agonist radioligand:: A [11C]-(+)-PHNO positron emission tomography study
    Willeit, Matthaeus
    Ginovart, Nathalie
    Graff, Ariel
    Rusjan, Pablo
    Vitcu, Irina
    Houle, Sylvain
    Seeman, Philip
    Wilson, Alan A.
    Kapur, Shitij
    NEUROPSYCHOPHARMACOLOGY, 2008, 33 (02) : 279 - 289
  • [20] Measurement of density and affinity for dopamine D2 receptors by a single positron emission tomography scan with multiple injections of [11C]raclopride
    Ikoma, Yoko
    Watabe, Hiroshi
    Hayashi, Takuya
    Miyake, Yoshinori
    Teramoto, Noboru
    Minato, Kotaro
    Iida, Hidehiro
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2010, 30 (03) : 663 - 673